在社区获得的肺炎中使用生物标志物引导的抗生素管理:一个随机对照试验
Ruud Duijkers1, Hendrik J Prins1, Martijn Kross2
1Department of Pulmonary Medicine, Northwest Hospital, Alkmaar, the Netherlands.
PloS one
|August 20, 2024
概括
使用C反应蛋白 (CRP) 和前素 (PCT) 的生物标志物引导治疗算法显著减少了社区获得性肺炎 (CAP) 的抗生素持续时间. 这种方法为优化住院患者抗生素使用提供了一个有希望的策略.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 确定社区获得性肺炎 (CAP) 的最佳抗生素治疗持续时间仍然是一个挑战.
- 作为指导抗生素治疗的生物标志物,如前素 (PCT) 和C反应蛋白 (CRP) 的实用性正在研究中.
研究的目的:
- 评估PCT和CRP导向治疗算法的有效性,以缩短住院CAP患者的抗生素持续时间.
- 将生物标志物引导的策略与非ICU环境中的标准护理进行比较.
主要方法:
- 一个随机的,开放的,多中心的试验,涉及468名CAP参与者.
- 治疗臂包括标准护理,PCT算法和CRP算法.
- 停用抗生素是基于预定义的生物标志物值.
主要成果:
- 在CRP组中,抗生素治疗的中位数为4天 (RR 0.70,p <0.001),而对照组中为7天.
- 与标准护理相比,PCT组的抗生素治疗时间中位数为5.5天 (RR 0.78,p <0.001).
- 在临床稳定性或住院时间的时间方面没有观察到显著差异.
结论:
- 以CRP和PCT为指导的治疗算法有效地减少了CAP患者抗生素暴露的持续时间.
- 需要进一步的研究来确认缩短抗生素持续时间的安全性.
- 以生物标志物为指导的战略显示出优化CAP管理中的抗生素管理的潜力.
更多相关视频
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
6.9K
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
33.0K
相关概念视频
01:28Pneumonia IV: Management
313
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
313
01:30Pneumonia III: Complications and Assessment
193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
00:57Antibiotic Selection
52.6K
Overview
52.6K
01:28Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174